Trial
NCT01858532
Study Of Diabetic Nephropathy With Atrasentan
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AbbVie
Collaborators
—
Condition
Diabetic Nephropathy
Intervention
Atrasentan
Why stopped
Strategic considerations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-24